H. Onat

发表

Correlation of HER 2/neu gene amplification with immunohistochemistry and other prognostic factors in breast carcinoma.

S. Ramadan, O. Yapicier, Selçuk Kihtir, 2011, Turk patoloji dergisi.

Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial.

D. Amadori, L. Dogliotti, O. Bertetto, 2007, European urology.

Treatment of Aggressive Non-Hodgkin’s Lymphoma With Dose-Intensified Epirubicin in Combination of Cyclophosphamide, Vincristine, and Prednisone (CEOP-100): A Phase II Study

S. Alıcı, F. Tas, H. Çamlıca, 2001, American journal of clinical oncology.

Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma.

J. Pignon, J. Bourhis, S. Leung, 2006, The Cochrane database of systematic reviews.

A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent or Metastatic Head and Neck Cancer

S. Bavbek, İ. Güllü, F. Demi̇relli̇, 2002, Journal of chemotherapy.

Precision medicine for colorectal cancer

Y. Baskın, S. Tüzmen, Y. Yıldırım, 2018, Precision Medicine in Cancers and Non-Communicable Diseases.

Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.

G. Basaran, H. Onat, M. Basaran, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors.

V. Yasasever, E. Darendeliler, H. Onat, 1999, Acta oncologica.

Brief weekly chemotherapy for elderly patients with intermediate-grade or high-grade non-Hodgkin's lymphoma.

H. Onat, S. Inanc, 1993, Journal of the National Cancer Institute.

Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients.

N. Dalay, H. Yazici, E. Topuz, 2009, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Bcl-2 gene rearrangements and apoptosis rates in patients with non-Hodgkin's lymphoma during chemotherapy.

N. Dalay, H. Yazici, Ĺ. Yalçinkaya, 1999, Clinical biochemistry.

Effect of cisplatin on erythropoietin and iron changes.

N. Dalay, V. Yasasever, H. Onat, 1993, European journal of cancer.

High-dose epirubicin and cisplatin in locally advanced undifferentiated nasopharyngeal carcinoma.

S. Bavbek, M. Esassolak, A. Haydaroǧlu, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prognostic Factors and Survival in Late Adolescent and Adult Patients With Small Round Cell Tumors

S. Bavbek, B. Bilgiç, E. Darendeliler, 2002, American journal of clinical oncology.

Chemotherapy+radiotherapy versus radiotherapy alone in nasopharynx carcinoma: Preliminary results of a meta-analysis based on individual patient data

S. Leung, D. Chua, F. Eschwège, 2004 .

EFFECT OF AGE ON CHARACTERISTICS AND CLINICAL BEHAVIOR OF ADULT AGRESSIVE NON-HODGKIN'S LYMPHOMA

S. Alıcı, S. Bavbek, M. Başaran, 2006 .

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

J. Pignon, J. Bourhis, S. Leung, 2006, International journal of radiation oncology, biology, physics.

Testicular germ cell tumor with gastric metastasis.

G. Erseven, K. Dinçol, A. Aydıner, 1993, Acta oncologica.

A Phase II Study of Cisplatin, Ifosfamide and Epirubicin Combination Chemotherapy in Adults with Nonmetastatic and Extremity Osteosarcomas

A. Atalar, L. Eralp, B. Bilgiç, 2008, Oncology.

Prognostic factors in patients with aggressive non-Hodgkin’s lymphoma without complete response to first-line therapy

S. Alıcı, S. Bavbek, M. Başaran, 2006, Advances in therapy.

Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.

H. Çamlıca, S. Bavbek, Y. Dizdar, 2004, Japanese journal of clinical oncology.

Aggressive Non-Hodgkin’s Lymphoma Treated at the Institute of Oncology, Istanbul: Treatment, Outcome, and Prognostic Factors

S. Alıcı, S. Bavbek, Y. Eralp, 2002, American journal of clinical oncology.

Skull Base Plasmacytoma in a Patient with Light Chain Myeloma.

S. Bavbek, B. Bilgiç, S. Sencer, 2004, Skull base : official journal of North American Skull Base Society ... [et al.].

Prognostic Factors in Localized Aggressive Non-Hodgkin’s Lymphoma

S. Alıcı, S. Bavbek, Y. Eralp, 2003, American journal of clinical oncology.

Sweet's syndrome and Hodgkin's disease.

G. Erseven, H. Onat, S. Inanc, 1994, Acta oncologica.

The efficacy of a five-drug antiemetic combination during chemotherapy regimens containing cisplatin or cyclophosphamide-doxorubicin.

E. Topuz, K. Dinçol, A. Aydıner, 1993, Journal of pain and symptom management.

Clinical outcome of rhabdomyosarcoma in adolescent and adult patients: single center experience from Turkey.

G. Basaran, S. Bavbek, B. Bilgiç, 2007, The Tohoku journal of experimental medicine.